Skip to main content

Table 6 Gene model validation test by BNN analysis. Malignant or benign group allocation probability values for the unknown samples

From: The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management

Unknown samples

Benign probability

Malignant Probability

Predicted diagnosis

Cytological diagnosis

Pathological diagnosis

BRAF status

A

0.0302

1.0000

Malignant

SPTC

Malignant

V600E

B

0.0011

1.0000

Malignant

SPTC

Malignant

V600E

C

0.0004

0.9996

Malignant

SPTC

Malignant

V600E

D

0.0000

1.0000

Malignant

SPTC

Malignant

V600E

E

0.3242

0.6758

Malignant

SPTC

Malignant

V600E

F

0.0223

0.9777

Malignant

SPTC

Malignant

V600E

G

0.0009

0.9991

Malignant

SPTC

Malignant

WT

H

0.1759

0.8241

Malignant

SPTC

Malignant

WT

I

0.0847

0.9153

Malignant

SPTC

Malignant

V600E

L

0.2007

0.7993

Malignant

SPTC

Malignant

WT

M

0.0000

1.0000

Malignant

SPTC

Malignant

WT